Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $92,779.39 +3.11%
Ethereum $3,244.69 +4.53%
BNB $906.86 +0.99%
Optimism $0.33 +3.65%
Arbitrum $0.22 +5.01%
Solana $138.10 +1.75%
Polygon $0.22 +2.77%
Cosmos $2.32 +4.63%
Avalanche $14.13 +4.23%

Bitcoin $92,779.39 +3.11%
Ethereum $3,244.69 +4.53%
BNB $906.86 +0.99%
Optimism $0.33 +3.65%
Arbitrum $0.22 +5.01%
Solana $138.10 +1.75%
Polygon $0.22 +2.77%
Cosmos $2.32 +4.63%
Avalanche $14.13 +4.23%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B